Afrezza as Standard of care. What is the plan?
Type one, type two. Endo, General Care physician?
How do you plan to increase scripts and what do your next 12 month projections for weekly scripts look like?
What are your projections to break even? In other words, how long until we reach break even?
Is MNKD running Afrezza commercials on television screens in physician offices? (Outcome Health for in physician's waiting room TV Advertising.)
what does your overall advertising promotional campaign look like moving forward and what type of media mix do you plan?
What are the fixed manufacturing costs per unit, and what are the variable manufacturing costs per unit. The "unit" can be any measure they like, but one box in the new configuration is probably the most sensible.
we are charging $.79 a unit?
what is a Mannkind Cares Pharmacy and are titration packs available only at such a pharmacy?
What is the refill rate look like over the last two years and what is the projection going forward? Also what are the action items to improve refill rates?
Even thought the estimated Primary Completion Date is July 2020, I would be interested in learning when there might be preliminary information released by the company related to the pediatric trial (ClinicalTrials.gov Identifier: NCT02527265). Might we hear something as early as Spring/Summer of 2019?
What exactly do they hope to accomplish and what results do they expect to see with the reveal of the stat study results?
What is the status of the 1-2 international deals that Mike has brought up twice (1 signed term sheet, 1 soon to be signed)?
What is being done to drive domestic sales of Afrezza?
Status of pipeline, particularly Trepostinil. Is Epipen competitor dead?
What specifically is being done to increase insurance coverage and what is the timetable for full coverage (eg: coverage comparable to our competitors)
What is up with RLS and will it ever bear fruit?
What ever happened to Torrey Pines and the pain patents. Why didn't this get any traction?
What 60 found Afrezza studies? From? Are they published, unpublished? Will they be published? How are you planning to use them?
What are you thinking regarding over the counter possibilities for afrezza sales?
What were the results from the targeted DTC ads that were run in select markets and how will this information be leveraged.?
Do you plan on any more dilutive cap raises this year?
Do sales teams/representatives visit PBM? Insurance companies?
Can Mike and team tell us anything about the STAT results? If so what can MNKD/Mike/Team tell tells?
What is the plan for STAT study result presentation? Detailed please.
The ADA STAT STUDY presentation to be posted on the internet?
Is MNKD/ Afrezza making in roads into any hospital pharmacies?
Many shareholders believe that the stock is grossly undervalued. What do you believe is a fair market cap valuation?
What do you think is a single and most important event / milestone fthe market is waiting for that would trigger a stock price move to that fair valuation?
